Why did Nvidia reach $4 trillion market cap?
How are Trump's tariffs impacting copper prices?
What led to Linda Yaccarino stepping down at X?
Why was the FTC 'click-to-cancel' rule blocked?
How will rising student loan payments affect borrowers?
What caused Revolut's valuation to jump to $65B?
How is AI reshaping advertising at WPP?
FDA Approves New Dosing Schedule For Eli Lilly's Kisunla In Alzheimer's Treatment
benzinga.com/news/fda/25/07/46319441/fda-approves-new-dosing-schedule-for-eli-lillys-kisunla-in-alzheimers-treatment
The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s (NYSE:LLY) Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA…
This story appeared on benzinga.com, 2025-07-09 13:49:19.